Tag: ASCO

Cancer ‘Big Data’ and Health Information Technology Expert, Joshua Mann, Joins Inspirata as Vice President for its Cancer Information Data Trust (CIDT) Program

| October 24, 2017 | 0 Comments

Tampa, FL, October 23, 2017/Globe Newswire – Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced today that Joshua (Josh) Mann recently joined the company as Vice President, Cancer Information Data Trust (CIDT) Program. In this capacity, he will be responsible for aligning the CIDT business strategy with systems design and data flow, […]

Continue Reading

Register Now for CAP Webinar on HER2 Testing in Gastroesophageal Adenocarcinoma

| January 13, 2017 | 0 Comments

  In 2010, results of a phase 3 randomized controlled trial showed that targeted therapy directed against HER2 statistically significantly prolonged overall survival compared with chemotherapy alone in patients with HER2–positive advanced GEA. Because there are important differences in HER2 expression, scoring, and outcomes in GEA relative to breast carcinoma, the need for guideline recommendations […]

Continue Reading

ASCO, AMP and CAP Issue New Joint Consensus Statement to Standardize Interpretation and Reporting of Sequence Variants in Cancer

| January 3, 2017 | 0 Comments

Last month a joint consensus statement developed by ASCO, the Association for Molecular Pathology (AMP), and the College of American Pathologists (CAP) on standardizing the interpretation and reporting of sequence variants in cancer was published online ahead of the January print issue of The Journal of Molecular Diagnostics. Thank you to a loyal reader for the […]

Continue Reading

ASCO, CAP, and ASCP Issue Joint Guideline on HER2 Testing in Gastroesophageal Cancers

| November 16, 2016 | 0 Comments

The American Society of Clinical Oncology (ASCO), the College of American Pathologists (CAP) and the American Society for Clinical Pathology (ASCP) have issued a joint guideline on HER2 testing for patients with gastroesophageal cancers. Read the full guideline and

Continue Reading

Cancer Moonshot Panel Releases “Blue Ribbon” Recommendations

| September 9, 2016 | 0 Comments

Download PDF of Recommendations The Washington Post (9/7, McGinley) highlights a report released by a “blue-ribbon panel” of “top cancer researchers and patient advocates” as part of the White House’s cancer moonshot. The report recommends that cancer researchers and others adopt a list of 10 goals aimed at improving cancer research, cancer patient care, and related matters. Congressional Quarterly (9/7, […]

Continue Reading

FDA Grants Accelerated Approval to Nivolumab in Classical Hodgkin Lymphoma

| May 17, 2016 | 0 Comments

More interesting news around PD-L1 for use in Classical Hodgkin lymphoma with specific indications as below. Another increasingly common example of companion diagnostics and personalized immunotherapies. On May 17, 2016, the U.S. Food and Drug Administration (FDA) granted accelerated approval to nivolumab (Opdivo; Bristol-Myers Squibb) for the treatment of patients with classical Hodgkin lymphoma that has […]

Continue Reading

Cancer News in the News Summary

| April 23, 2016 | 0 Comments

Lot going on in cancer care, data mining, cancer immunotherapy funding last week I thought worth sharing.  Clinical pathways, moonshot, data warehousing/mining, IT, immunotherapy to be key words in cancer care, treatment and research for the foreseeable future.  Is all of this activity helping or hurting large scale collaborations? Are ACS and ASCO talking with each other […]

Continue Reading

Quantify Biomarkers in situ in Tissue Sections with PerkinElmer’s NEW inForm 2.1 Tissue Finder software

| April 5, 2015 | 0 Comments

Extracting meaningful information from intact tissue is becoming ever more critical as researchers look for better ways to characterize molecular activity of cells within their native micro-environments. With PerkinElmer’s new inForm® 2.1 Tissue Finder™ advanced image analysis software you can accurately quantify, visualize and phenotype cells in situ in tissue sections. inForm Tissue Finder automates […]

Continue Reading

CAP and ASCO Sign MOU to Advance Patient Care

| December 23, 2014 | 0 Comments

The College of American Pathologists (CAP) and the American Society of Clinical Oncology (ASCO) recently announced a new partnership to optimize patient care and foster excellence in the practices of pathology and oncology through inter-professional education, advocacy, quality improvement, international outreach, and practice guideline development. As diagnosing cancer becomes more complex, communication between pathologists and clinical […]

Continue Reading

Researchers use immunotherapies to combat cervical cancer, melanoma

| June 3, 2014 | 0 Comments

Courtesy of AMA Wire Several major media sources report on research presented at the American Society of Clinical Oncology conference on immune therapies for different cancers. NBC Nightly News (6/2, story 5, 2:25, Curry) reported, “In medical news tonight a ground-breaking development in the fight against cancer. It involves one of the newest approaches, using a patient’s own […]

Continue Reading